Mouse Anti-DPPA4 Recombinant Antibody (1C1) (V2LY-0425-LY881)

Auvinen, P., Vehviläinen, J., Marjonen, H., Modhukur, V., Sokka, J., Wallén, E., ... & Kaminen-Ahola, N. (2022). Chromatin remodeler developmental pluripotency associated factor 4 (DPPA4) is a candidate gene for alcohol-induced developmental disorders. medRxiv.

Kubinyecz, O., Santos, F., Drage, D., Reik, W., & Eckersley-Maslin, M. A. (2021). Maternal Dppa2 and Dppa4 are dispensable for zygotic genome activation but important for offspring survival. Development, 148(24), dev200191.

Klein, R. H., & Knoepfler, P. S. (2021). DPPA2, DPPA4, and other DPPA factor epigenomic functions in cell fate and cancer. Stem cell reports, 16(12), 2844-2851.

Gretarsson, K. H., & Hackett, J. A. (2020). Dppa2 and Dppa4 counteract de novo methylation to establish a permissive epigenome for development. Nature Structural & Molecular Biology, 27(8), 706-716.

De Iaco, A., Coudray, A., Duc, J., & Trono, D. (2019). DPPA2 and DPPA4 are necessary to establish a 2C‐like state in mouse embryonic stem cells. EMBO reports, 20(5), e47382.

Li, L., Wang, Y., Wang, Q., Qu, J., Wei, X., Xu, J., ... & Zhang, Y. (2019). High developmental pluripotency‑associated 4 expression promotes cell proliferation and glycolysis, and predicts poor prognosis in non‑small‑cell lung cancer. Molecular Medicine Reports, 20(1), 445-454.

Eckersley-Maslin, M., Alda-Catalinas, C., Blotenburg, M., Kreibich, E., Krueger, C., & Reik, W. (2019). Dppa2 and Dppa4 directly regulate the Dux-driven zygotic transcriptional program. Genes & development, 33(3-4), 194-208.

Klein, R. H., Tung, P. Y., Somanath, P., Fehling, H. J., & Knoepfler, P. S. (2018). Genomic functions of developmental pluripotency associated factor 4 (Dppa4) in pluripotent stem cells and cancer. Stem cell research, 31, 83-94.

Somanath, P., Bush, K. M., & Knoepfler, P. S. (2018). ERBB3-binding protein 1 (EBP1) is a novel developmental pluripotency-associated-4 (DPPA4) cofactor in human pluripotent cells. Stem Cells, 36(5), 671-682.

Jabbar, S., Belden, W., Gangisetty, O., & Sarkar, D. K. (2017). Developmental pluripotency associated 4: A novel putative predictor for prognosis of aggressive prolactin secreting tumors in the pituitary.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols